Which amino acids accumulate in maple syrup urine disease?
Because free ammonia in the blood is toxic to the body, it is transported in which of the following non-toxic forms?
An infant presented with vomiting, malnutrition, blue eyes, blonde hair & fair skin. On investigation, Guthrie test was positive. All are true regarding this disease EXCEPT:
Phenylketonuria is due to a deficiency of:
In a patient with maple syrup urine disease, all of the following amino acids should be restricted in diet except?
Which of the following is not a substrate for gluconeogenesis?
Which of the following compounds is not formed with the involvement of glycine?
Which dietary deficiency of a vitamin can cause pellagra?
Pyridoxine deficiency leads to altered metabolism of?
A 2-month-old infant presents with vomiting, lethargy, and metabolic acidosis. Blood tests reveal elevated levels of ammonia. What is the most likely diagnosis?
Explanation: ***All branched-chain amino acids*** - Maple syrup urine disease (MSUD) is characterized by a deficiency in the **branched-chain alpha-keto acid dehydrogenase complex**, which is responsible for the breakdown of branched-chain amino acids (BCAAs). - This deficiency leads to the accumulation of **leucine, isoleucine, and valine**, along with their corresponding alpha-keto acids, in the blood and urine. - The distinctive **maple syrup odor** in the urine is caused by the accumulation of branched-chain keto acids derived from all three BCAAs. *Leucine* - While leucine is one of the BCAAs that accumulates in MSUD, it is not the *only* amino acid involved. - The accumulation of **leucine** is particularly associated with the severe neurological symptoms seen in MSUD, as it is the most neurotoxic of the three BCAAs. *Valine* - Valine is another BCAA that accumulates due to the metabolic block in MSUD. - However, the disease involves the accumulation of all three BCAAs, not just valine in isolation. *Isoleucine* - Isoleucine is the third BCAA that accumulates in MSUD due to the defective enzyme. - Like leucine and valine, isoleucine and its corresponding keto acid accumulate in blood and urine when the branched-chain alpha-keto acid dehydrogenase complex is deficient.
Explanation: ***Alanine and glutamine*** - **Glutamine** is the primary transporter of ammonia from most peripheral tissues to the liver and kidneys, where it can be safely released and processed. - **Alanine** transports ammonia from muscles to the liver via the glucose-alanine cycle, allowing for hepatic urea synthesis and glucose production. *Glutamine and urea* - While **glutamine** is a major ammonia transporter, **urea** is the *end product* of ammonia detoxification and is primarily synthesized in the liver for excretion. - Urea itself is not a transport form of ammonia *within* the blood before its synthesis; rather, it is the waste product. *Phenylalanine and methionine* - **Phenylalanine** and **methionine** are essential amino acids involved in protein synthesis and various metabolic pathways. - They do not serve as significant carriers for the transport of toxic free ammonia in the bloodstream. *Histidine and urea* - **Histidine** is an amino acid involved in protein synthesis and histamine production, but not primarily in ammonia transport. - As mentioned, **urea** is the final excretory form of detoxified ammonia, not a transport form within the blood.
Explanation: ***Hypopigmentation due to tryptophan deficiency*** - The characteristic **hypopigmentation** (fair skin, blonde hair, blue eyes) in **phenylketonuria (PKU)** is due to **tyrosine deficiency**, not tryptophan deficiency. - **Phenylalanine hydroxylase (PAH)** deficiency leads to accumulation of phenylalanine, which cannot be converted to **tyrosine**. - **Tyrosine** is the precursor for **melanin synthesis** via the enzyme **tyrosinase**, so tyrosine deficiency results in decreased melanin production and hypopigmentation. *Phenyl acetate positive in urine* - In **phenylketonuria (PKU)**, **phenylalanine** accumulates and is shunted to alternative metabolic pathways, leading to the production and excretion of **phenylacetate, phenylpyruvate, and phenyllactate** in the urine. - The presence of these metabolites gives the urine a characteristic **mousey or musty odor**. *Mental retardation is present* - If **phenylketonuria (PKU)** is left untreated, the accumulation of **phenylalanine** is neurotoxic and leads to severe, **irreversible intellectual disability** and **developmental delay**. - Early detection through newborn screening (the **Guthrie test** detects elevated blood phenylalanine) and dietary phenylalanine restriction are crucial to prevent this outcome. *Due to PAH enzyme defect* - **Phenylketonuria (PKU)** is primarily caused by a deficiency in the enzyme **phenylalanine hydroxylase (PAH)**, which is responsible for converting phenylalanine to tyrosine. - This **autosomal recessive genetic disorder** leads to the accumulation of phenylalanine in the blood and tissues, causing the clinical manifestations.
Explanation: ***Phenylalanine hydroxylase (PAH)*** - **Phenylketonuria (PKU)** is an autosomal recessive disorder caused by a deficiency of the enzyme **phenylalanine hydroxylase (PAH)**. - This enzyme is crucial for converting the amino acid **phenylalanine** to **tyrosine**. *Phenylalanine* - Phenylalanine is the **substrate** that accumulates in PKU due to the enzyme deficiency, not the deficiency itself. - High levels of phenylalanine are **toxic** to the brain and lead to the clinical manifestations of PKU. *Galactokinase* - Deficiency of **galactokinase** is associated with **galactosemia type II**, a disorder of galactose metabolism. - This condition is characterized by **cataracts** and typically does not involve the neurologic symptoms seen in PKU. *Tyrosinase* - **Tyrosinase** deficiency is the primary cause of **oculocutaneous albinism type 1**, affecting melanin synthesis. - It results in hypopigmentation of the skin, hair, and eyes, which is unrelated to PKU.
Explanation: ***Methionine*** - **Maple syrup urine disease (MSUD)** is a disorder affecting the metabolism of **branched-chain amino acids (BCAAs)**: leucine, isoleucine, and valine. - Therefore, methionine, which is not a BCAA, typically does not need to be restricted and is, in fact, an **essential amino acid** crucial for protein synthesis. *Isoleucine* - **Isoleucine** is a branched-chain amino acid (BCAA) whose metabolism is impaired in MSUD due to a deficiency in **branched-chain alpha-keto acid dehydrogenase complex**. - Accumulation of isoleucine and its corresponding alpha-keto acid is toxic and must be **restricted in the diet**. *Leucine* - **Leucine** is another branched-chain amino acid (BCAA) that cannot be properly metabolized in MSUD. - High levels of leucine and its metabolites are particularly **neurotoxic** and contribute to the characteristic neurological symptoms, necessitating strict dietary restriction. *Valine* - **Valine** is the third branched-chain amino acid (BCAA) whose breakdown is defective in MSUD. - Dietary restriction of valine is essential to prevent its accumulation, which can lead to metabolic crises and **developmental delays**.
Explanation: ***Leucine*** - **Leucine** is an exclusively **ketogenic amino acid**, meaning its breakdown products can only be converted into **ketone bodies** or fatty acids, not glucose. - It does not have a carbon skeleton that can be directly converted into **pyruvate** or **oxaloacetate**, which are key intermediates in gluconeogenesis. *Lactate* - **Lactate** is a major substrate for gluconeogenesis, particularly during exercise or fasting. - It is converted to **pyruvate** by **lactate dehydrogenase**, and pyruvate can then enter the gluconeogenic pathway. *Propionate* - **Propionate** is a fatty acid with an odd number of carbon atoms, primarily derived from the catabolism of odd-chain fatty acids or from bacterial fermentation in the colon. - It can be converted into **succinyl CoA**, an intermediate of the citric acid cycle, which can then be used for gluconeogenesis. *Glycerol* - **Glycerol**, released during the breakdown of triglycerides, is an important substrate for gluconeogenesis. - It is phosphorylated to **glycerol-3-phosphate**, which is then oxidized to **dihydroxyacetone phosphate (DHAP)**, an intermediate in glycolysis and gluconeogenesis.
Explanation: ***Thyroxine*** - **Thyroxine** (and other thyroid hormones) are derived from the amino acid **tyrosine**. - Their synthesis involves iodination and coupling reactions of tyrosine residues within the protein **thyroglobulin**. *Heme* - **Glycine** is a direct precursor for the initial step in **heme synthesis**. - It condenses with **succinyl CoA** to form α-amino-β-ketoadipate, which then decarboxylates to form δ-aminolevulinate (ALA). *Purines* - **Glycine** contributes part of its structure to the **purine ring**. - Specifically, the **nitrogen at position 7** and the **carbons at positions 4 and 5** of the purine ring are derived from glycine. *Glutathione* - **Glutathione** is a tripeptide composed of three amino acids: **glutamate**, **cysteine**, and **glycine**. - **Glycine** is the C-terminal amino acid of glutathione and is essential for its structure and function as an antioxidant.
Explanation: ***Niacin*** - **Pellagra** is classically described by the "4 D's": **dermatitis**, **diarrhea**, **dementia**, and eventually **death**, all of which are caused by a deficiency in **niacin (Vitamin B3)**. - Niacin is crucial for energy metabolism and DNA repair, and its deficiency affects rapidly dividing cells, especially in the skin, gastrointestinal tract, and nervous system. *Vitamin A* - Deficiency in **Vitamin A** primarily leads to **vision problems**, including **night blindness** and, in severe cases, **xerophthalmia** and irreversible blindness. - While it can impact immune function and epithelial integrity, it does not cause the characteristic triad of pellagra. *Folate* - A deficiency in **folate (Vitamin B9)** is primarily associated with **megaloblastic anemia**, which involves enlarged, immature red blood cells. - It does not cause the dermatological, gastrointestinal, or neurological symptoms seen in pellagra. *Vitamin B12* - **Vitamin B12 (cobalamin) deficiency** also causes **megaloblastic anemia**, but it is uniquely associated with **neurological symptoms** such as peripheral neuropathy, cognitive impairment, and subacute combined degeneration of the spinal cord. - While there is some neurological overlap, its clinical presentation is distinct from pellagra and does not involve the characteristic dermatitis or severe diarrhea.
Explanation: ***Tryptophan*** - **Pyridoxine (vitamin B6)** is a critical coenzyme in the metabolism of **tryptophan**, particularly in its conversion to **niacin** and serotonin. - A deficiency leads to an accumulation of abnormal tryptophan metabolites, such as **xanthurenic acid**, which can be excreted in the urine. *Phenylalanine* - The metabolism of phenylalanine involves its conversion to tyrosine, a process catalyzed by **phenylalanine hydroxylase**, which does not directly require pyridoxine. - Deficiencies in phenylalanine metabolism often point to issues like **phenylketonuria**. *Methionine* - Methionine metabolism involves a cycle that generates **S-adenosylmethionine (SAM)** and then homocysteine. - While vitamin B6 is involved in the transsulfuration pathway (converting homocysteine to cysteine), its primary direct impact on methionine metabolism itself is less pronounced than on tryptophan. *Tyrosine* - Tyrosine is synthesized from phenylalanine and is a precursor for **catecholamines** and thyroid hormones. - Its metabolism does not directly rely on pyridoxine as a coenzyme in the main initial steps.
Explanation: ***Urea Cycle Disorder*** - The combination of **vomiting**, **lethargy**, metabolic acidosis, and **elevated ammonia** in a 2-month-old infant is highly indicative of a urea cycle disorder due to the impaired detoxification of ammonia. - **Ammonia is neurotoxic**, explaining the lethargy, and its accumulation leads to severe metabolic derangements. *Phenylketonuria* - Characterized by the inability to metabolize **phenylalanine**, leading to its accumulation and neurological damage. - While it can cause developmental delay and seizures, it typically does **not present with acute metabolic acidosis** or hyperammonemia in infancy. *Galactosemia* - An inherited disorder of **galactose metabolism** that can cause vomiting, lethargy, and liver dysfunction, but is typically associated with **jaundice**, hepatomegaly, and **reducing substances in urine**, not primarily hyperammonemia and metabolic acidosis as the presenting features. - The primary defect is in the conversion of galactose to glucose, not ammonia detoxification. *Maple Syrup Urine Disease* - A rare metabolic disorder caused by a defect in the metabolism of **branched-chain amino acids** (leucine, isoleucine, valine). - Presents with feeding difficulties, lethargy, and a characteristic **sweet-smelling urine** ("maple syrup" odor), which is not mentioned in this case.
Get full access to all questions, explanations, and performance tracking.
Start For Free